Revive Therapeutics (31R) Financial Statements
Revive Therapeutics Financial Overview
Revive Therapeutics's market cap is currently $5.35M. The company's EPS TTM is $-0.02; its P/E ratio is -16.67; Revive Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Sep 25 | Sep 24 | Sep 23 | Sep 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -189.00 | $ -248.00 | $ -328.00 | $ -434.00 | $ -578.00 |
| Operating Income | $ -1.05M | $ -1.65M | $ -3.29M | $ -5.52M | $ -17.83M |
| EBITDA | $ -1.05M | $ -11.01M | $ -5.60M | $ -5.52M | $ -17.74M |
| Net Income | $ -1.02M | $ -11.01M | $ -5.62M | $ -6.32M | $ -17.83M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 14.83K | $ 24.56K | $ 773.07K | $ 2.09M | $ 3.92M |
| Total Assets | $ 283.38K | $ 205.02K | $ 10.64M | $ 14.25M | $ 17.07M |
| Total Debt | $ 0.00 | $ 66.87K | $ 25.22K | $ 219.69K | $ 327.73K |
| Net Debt | $ -14.83K | $ 42.31K | $ -797.85K | $ -1.87M | $ -3.59M |
| Total Liabilities | $ 4.30M | $ 3.66M | $ 3.40M | $ 3.60M | $ 4.46M |
| Stockholders' Equity | $ -4.02M | $ -3.46M | $ 7.23M | $ 10.65M | $ 12.60M |
| Cash Flow | |||||
| Free Cash Flow | $ -158.53K | $ -807.66K | $ -3.29M | $ -6.03M | $ -13.06M |
| Operating Cash Flow | $ -158.53K | $ -807.66K | $ -3.29M | $ -6.03M | $ -13.06M |
| Investing Cash Flow | $ 0.00 | $ -30.00K | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 148.80K | $ 39.15K | $ 1.98M | $ 4.20M | $ 376.35K |
Currency in CAD
